Burning Rock Biotech 

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$131,616
$148,554
$133,082
$126,022
Gross Profit
98,844
108,103
97,401
89,422
EBITDA
-3,284
1,349
-15,179
EBIT
-16,131
-11,497
Net Income
-16,758
-9,702
-13,500
-81,294
Net Change In Cash
131,616
148,554
133,082
126,022
Free Cash Flow
16,393
-44,349
-23,527
13,085
Cash
463,994
452,721
495,145
519,849
Basic Shares
1,076
1,076
1,076
107,613

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$515,822
$537,435
$563,238
$507,862
Gross Profit
362,400
363,227
380,039
364,146
EBITDA
-270,232
-517,901
-856,311
-746,496
EBIT
-322,432
-651,301
-980,407
-794,262
Net Income
-346,626
-653,689
-971,233
-796,697
Net Change In Cash
515,822
537,435
563,238
507,862
Free Cash Flow
-98,238
-265,167
-518,839
-691,334
Cash
519,849
615,096
905,451
1,431,317
Basic Shares
1,029
1,024
1,039
1,042

Earnings Calls

QuarterEPS
2025-06-30
-$0.90
2025-03-31
-$1.25
2024-12-31
-$7.87
2024-09-30
-$0.48